SyAqua Group has announced a significant leap forward in its mission to enhance and diversify the genetic resources and market reach. This strategic acquisition will not only bolster its existing portfolio but also pave the way for new market opportunities, and most importantly, to protect its strain security with another genetic nucleus and broodstock multiplication facility in the USA.
Strategic acquisition and market expansion
This latest acquisition of the assets of Primo Broodstock USA LLC (“Primoâ€), a company that has been known for its pioneering work in the development of specific pathogen free (SPF) and disease tolerant genetic lines, marks a pivotal moment for SyAqua. Primo has an impressive legacy, having been the first to leverage SPF populations out of Ecuador to address disease challenges in major markets like Mexico and China. This acquisition allows SyAqua to tap into robust and well-established genetic resources while significantly expanding its US genetic nucleus and broodstock multiplication facilities.
Unlocking new market segments
With Primo’s integration, SyAqua now has the potential to tap new genetic stocks developed over years of selective breeding for disease tolerance. This strategic move opens potential for more innovative selection strategies that will bring to its customers enhanced performance even in the most challenging production environments. SyAqua anticipates a significant increase in supply of its US broodstock production capacity by the end of 2024, targeting potential production of more than 230,000 broodstock/year. This acquisition will enhance the ability to meet the growing demand in major shrimp-producing markets.
Innovative infrastructure enhancements
SyAqua Americas continues to refine its biofloc based raceway production technologies, known for efficiency and superior broodstock. This expansion, coupled with new state of the art packing lines, will ensure stringent environmental control and top-notch product quality. These advancements highlight the dedication to sustainability and operational excellence.
Commitment to genetic excellence and sustainability
The long-term commitment to balanced genetic selection programs remains unwavering. It has consistently delivered some of the highest-performing broodstocks globally. The acquisition of Primo enriches SyAqua’s genetic resources, aligning with the vision of business sustainability and a commitment to managing environmental impact of the blue economy, particularly in Asian shrimp farming industry. Furthermore, the alliance with Ocean 14 Capital Fund strengthens this dedication to sustainable practices and innovative solutions in aquaculture.
